APC	antigen-presenting cell
ARG1	Arginase 1
B2M	β2-microglobulin
cHL	classical Hodgkin’s lymphoma
CTL	cytotoxic T lymphocyte
CAF	cancer-associated fibroblast
DC	dendritic cell
DLBCL	diffuse large B cell lymphoma
DNMTi	DNA methyltransferase inhibitor
EZH2	enhancer of zeste homolog 2
FDA	Food and Drug Administration
FasL	factor-related apoptosis antigen ligand
FL	follicular lymphoma
HNC	head and neck cancer
HNSCC	head and neck squamous cell carcinoma
H3K27me3	histone h3 lysine 27 tri-methylation
ICB	immune checkpoint blocker
ITIM	immunoreceptor tyrosine-based inhibitory motif
ITSM	immunoreceptor tyrosine-based switch motif
ILC	innate lymphoid cell
IDO	indoleamine 2,3-dioxygenase
IFN	interferon
iNOS	inducible nitric oxide synthase
JAK	Janus kinase
LSD1	lysine-specific histone demethylase 1
LAG-3	lymphocyte activation gene 3
MHC	major histocompatibility complex
MAPK	mitogen-activated protein kinase
mCRPC	metastatic castration-resistant prostate cancer
mAb	monoclonal antibody
MDSC	myeloid-derived suppressor cell
NK	natural killer cell
NSCLC	non-small cell lung cancer
NCI	National Cancer Institute
NF-κB	nuclear factor kappa-light-chain-enhancer of activated B cells
PD-1	programmed cell death receptor 1
PD-L1	programmed cell death ligand 1
PD-L2	programmed cell death ligand 2
PRC2	polycomb repressive complex 2
PTEN	phosphatase and tensin homolog
RT	radiotherapy
STAT1	signal transducer and activator of transcription 1
TDLNs	tumor-draining lymph nodes
TME	tumor microenvironment
TCR	T cell receptor
TAM	tumor-associated macrophage
TNF-α	tumor necrosis factor α
Th1 cell	T helper 1 cell
Treg	regulatory T cell
TGF-β	transforming growth factor β
TREM2	triggering receptor expressed on myeloid cells 2
TIM-3	T-cell immunoglobulin mucin 3
UC	urothelial carcinoma
VEGF	vascular endothelial growth factor